Cost-effectiveness in the treatment of schizophrenia

European Psychiatry

Volumn 11, Issue 3, 1996, Pages 137-143

  Knapp, M R J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cost effectiveness; cost utility; health economics; schizophrenia

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; TREATMENT PLANNING;

EID: 0029898707     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)85179-0     Document Type: Article

References (47)

1. Addington DE, Jones B, Bloom D, Chouinard G, Remington G, Albright P. Reduction of hospital days in chronic schizophrenia patients treated with risperidone: a retrospective study. Clin Therapeut 1993;15:917-26
2. Anderson J , Dayson D, Willis W et al. The TAPS Project. 13: Clinical and social outcomes of long-stay psychiatric patients after one year in the community. Br J Psychiatry 1993;162 (suppl 19):45-56
3. Andrews G, Hall W, Goldstein, G et al The economic costs of schizophrenia: implications for public policy. Arch of Gen Psychiatry 1985;42:537-43
4. Backhouse ME, Backhouse RJ, Edey SA. Economic evaluation bibliography. Health Econ 1992;1(supp1):1-236
5. Burns T, Raftery J, Beardsmoore A, McGuigan S, Dickson M. A controlled trial of home-based acute psychiatric services. II: treatments patterns and costs. Br J Psychiatry 1993;163:55-61
6. Carr-Hill R, Morris J. Current practice in obtaining the 'Q' in QALYs: a cautionary note. Br Med J 1991;303:699-701
7. Chisholm D, Healey A, Knapp MRJ. QALYs and mental health care. Soc Psychiatry Psychiatr Epidemiol 1996:(in press)
8. Clark RE, Fox TS. A framework for evaluating the economic impact of case management. Hosp Comm Psychiatry 1993;44:469-73
9. Coid J. Failure in community care: psychiatric dilemma. Br Med J 1994;308:805-6
10. Davies LM, Drummond MF. The economic burden of schizophrenia, Psychiatr Bull 1990;14:522-5
11. Davies LM, Drummond MF. Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. Br J Psychiatry 1993;162:38-42
12. Department of Health. Mental Illness Handbook (of The Health of the Nation). London: HMSO, 1993
13. Donnolly M, Mays N, McGilloway S et al. Leaving long-stay hospital in Northern Ireland: care in the community for people discharged from psychiatric and mental handicap hospitals. Queen's Univ Belfast, 1994
14. Drummond MF. Principles of Economic Appraisal in Health Care. Oxford: Oxford University Press, 1980
15. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation and Health Care Programmes. Oxford: Oxford Medical Publications, 1987
16. Eichelman B, Hartwig A. Ethical issues in selecting patients for treatment with clozapine: a commentary. Hosp Comm Psychiatry 1990;41:880-2
17. Goldacre M, Shiwach R, Yeates D. Estimating incidence and prevalence of treated psychiatric disorders from routine statistics: the example of schizophrenia. J Epidemiol Public Health 1994; (in press)
18. Gudex C. The QALY: how can it be used? In: Baldwin S, Godfrey C, Propper C, eds. Qualty of Life: Perspectives and Policies. London: Routledge, 1990
19. Hallam A, Beecham JK, Knapp MRJ, Fenyo A. The costs of accommodation and care: community provision for former long-stay psychiatric hospital patients. Eur Arch Psychiatry Clin Neurosci 1994;243:304-10
20. Healy D. Psychopharmacology and the ethics of resource allocation. Br J Psychiatry 1993;162:23-9
21. Huxley P. Social services assessment and care management: getting it right. J Ment Health 1992;1:285-94
22. Kavanagh S, Stewart A. Economic evaluations of mental health care: modes and methods. In: Knapp MRJ, ed. The Economic Evaluation of Mental Health Care. Aldershot: Arena, 1995
23. Kingdon D F, Turkington D. Cognitive Therapy in Schizophrenia. New York: Guilford Press, 1993
24. Knapp MRJ. The health economics of schizophrenia treatment. Clinician 1994;12(2):39-52
25. Knapp MRJ, ed. The Economic Evaluation of Mental Health Care. Aldershot: Arena, 1995a
26. Knapp MRJ. Costing mental health services: towards an understanding of cost-effectiveness. In: Creed F, Tyrer P, eds. Evaluation of Community Psychiatric Services. Cambridge: Cambridge University Press, 1995b
27. Knapp MRJ. Making music out of noise: the cost function approach to evaluation. Br J Psychiatry 1996;(suppl):(in press)
28. Knapp MRJ, Cambridge P, Thomason C, Beecham JK, Allen C, Darton, R. Care in the Community: Challenge and Demonstration. Aldershot: Ashgate, 1992
29. Knapp MRJ, Beecham J. Programme level and systems level health economics considerations. In: Thornicroft G, Knudson HC, eds. Mental Health Service Evaluations. Cambridge: Cambridge University Press, 1996
30. Knapp MRJ, Beecham JK, Koutsogeorgopoulou V et al. A controlled study of home- versus hospital-based care for people with serious mental illness: service use and costs. Br J Psychiatry 1994;165:195-203
31. Knapp MRJ, Beecham J, Fenyo A, Hallam A. Predicting costs from needs and diagnosis: community mental health care for former hospital in-patients. Br J Psychiatry 1995; (suppl)
32. McCrone P, Beecham JK, Knapp MRJ. Community psychiatric nurses in an intensive community support team: cost-effectiveness comparisons with generic CPN care. Br J Psychiatry 1994;165:218-21
33. Marks IM, Connolly J, Muijen M., McNamee G, Audini B, Lawrence RE. Home-based vs in/out-patient care for serious mental illness: a controlled study. Br J Psychiatry 1994;165:179-84
34. Melzer D, Hale AS, Malik SJ, Hogman GA, Woods S. Community care for patients with schizophrenia one year after hospital discharge. Br Med Journal 1991;303:1023-6
35. North C, Ritchie J. Factors Influencing the Implementation of the Care Programme Approach. London: HMSO, 1993
36. Pelonaro AL, Elliott RL. Ethical and clinical considerations in selecting patients who will receive clozapine. Hosp Comm Psychiatry 1990;41:878-80
37. Ritchie JH, Dick D, Lingham R. The Report of the Inquiry into the Care and Treatment of Christopher Clunis London: HMSO, 1994
38. Rosser R. From health indicators to Quality Adjusted Life Years: technical and ethical issues. In: Hopkins A, Costain D, eds. Measuring the Outcomes of Medical Care London: RCP Press, 1990
39. Rupp A, Keith SJ. The costs of schizophrenia. Psychiatr Clin North Am 1993;16:413-23
40. Schneider J. Costing the care programme approach. In: Knapp MRJ, ed. The Economic Evaluation of Mental Health Care. Aldershot: Arena, 1995
41. Selai C, Rosser R. The role of quality of life measurement in psychiatry. Curr Med Lit - Psychiatry 1993;4:67-71
42. Stein LI, Test MA. Alternative to mental hospital treatment: conceptual model, treatment program and clinical evaluation. Arch Gen Psychiatry 1980;37:392-7
43. Tarrier N, Beckett R , Harwood MS, Baker A, Yusopoff L, Ugarteburn I. A trial of two cognitive-behavioural methods of treating drug-resistant residual psychoticsymptoms in schizophrenic patients: I, Outcome. Br J Psychiatry 1993; 162:524-32
44. Weller MPI, Muijen M. Dimensions of Community Mental Health Care. London: WB Saunders, 1993
45. Wilkinson G, Croft-Jeffreys C, Krekorian H, McLees S, Falloon I. QALYs in psychiatric care? Psychiatr Bull 1990;14:582-5
46. Wilkinson G, Williams B, Krekorian H, McLees S, Falloon I. QALYs in mental health: a case study. Psychologic Med 1992;22:725-31
47. Williams A. The cost benefit approach. Br Med Bull 1974;30:252-6